Tags » CBD

Posts
Since the 2018 Farm Bill passed in December 2018, removing hemp from the Controlled Substances Act and thus legalizing it under federal law, consumer goods containing the hemp-derivative cannabidiol (CBD) have become exceptionally popular. With that (More)
On November 25, 2019, the U.S. Food & Drug Administration (FDA) announced that it had issued warning letters to 15 U.S. businesses engaged in the sale of products containing cannabidiol (CBD); that it had published a revised Consumer Update d (More)
Duane Morris Partner Frederick Ball is quoted in the Agri-Pulse article "Regulatory Uncertainty Hangs Over Production of Industrial Hemp." Nearly a year after the 2018 farm bill legalized industrial hemp production, the business community continue (More)
Duane Morris partner Neville M. Bilimoria is quoted in the Law360 article, "CBD Rules In Limbo As FDA Grapples With New Cannabis Era." Hemp may have been legalized less than a year ago, but CBD derived from it is already on its way to becoming a (More)
[caption id="attachment_37" align="alignleft" width="125"] Seth A. Goldberg[/caption] The long awaited regulations establishing a regulatory framework under the 2018 Farm Bill passed last December were issued today (10/29/19).  An Interim Final R (More)
Despite recent bipartisan calls on the FDA to regulate hemp-derived CBD products, the U.S. Food & Drug Administration appears to be adhering to the status quo, at least with respect to issuing warning letters to companies deemed noncompliant wi (More)
Despite recent bipartisan calls on the FDA to regulate hemp-derived CBD products, the U.S. Food & Drug Administration appears to be adhering to the status quo, at least with respect to issuing warning letters to companies deemed noncompliant with (More)
[caption id="attachment_37" align="alignleft" width="125"] Seth A. Goldberg[/caption] Seth A. Goldberg, Duane Morris partner and team lead of the Cannabis Industry Group, spoke with Law.com’s Higher Law on the health issues surrounding vaping and (More)
The past week has shown the challenges that the cannabis industry supply chain—manufacturers, processors, distributors and dispensaries—faces, as regulators target claims relating to the health benefits of CBD and media outlets report, without an (More)
[caption id="attachment_37" align="alignleft" width="125"] Seth A. Goldberg[/caption] I have been writing about the recent reports of vaping related deaths and illnesses, and allegations that in some instances cannabis vaping could be a contributi (More)